Fatigue Intervention Co-design Study in Teenagers and Young Adults With Cancer

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02719561

Enrollment

Registered

2016-03-25

Start date

2016-06-30

Completion date

2017-02-28

Last updated

2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue

Brief summary

Fatigue is one of the most common and distressing symptoms in teenage and young adult cancer patients. Despite this, there has been virtually no research evaluating treatment for cancer-related fatigue in this young patient group. The investigators are undertaking a small qualitative study to co-design a fatigue intervention, that will then be evaluated in future research to assess its effectiveness.

Detailed description

This small qualitative study will involve 7-10 patients who are within one year of completing cancer treatment, as well as some parents. Participants will be recruited from one centre, the Cambridge Teenage and Young Adult cancer Principal Treatment Centre. The three phases will involve a) participants being interviewed individually and attending a focus group, b) patients receiving the prototype co-designed intervention, and c) participants being interviewed after the intervention to provide feedback to allow further refinement of the intervention. The intervention will be delivered by an Allied Health Professional in the setting that participants have chosen. It is likely to involve, at a minimum, education about fatigue and support with increasing activity. It will not include administration of any medication.

Interventions

BEHAVIORALFatigue Intervention

The Fatigue Intervention will include education, energy conservation and activity promotion

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

16 Years to 27 Years

Healthy volunteers

Inclusion criteria

Patients: * Aged 16-27 with a diagnosis of cancer * Currently or previously known to the Cambridge Teenage and Young Adult cancer service * Primary cancer treatment completed within one year of recruitment OR on maintenance treatment for leukaemia. * A screening score of ≥5 in a 10-item numerical rating scale of fatigue severity over the last month * Able to give informed consent Parents: * The parent of a patient participant or a patient who would be eligible to participate * The patient consents to the parent being approached about the study * The parent is able to give informed consent

Exclusion criteria

* Current participation in another clinical trial

Design outcomes

Primary

Measure	Time frame
Participant-reported feedback on design content as assessed via interviews	3 months
Participant-reported feedback on design acceptability as assessed via interviews	3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026